Frontier Biotechnologies Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	248.98	526.66	550.89	800.85
Trading Asset Securities	-	600.53	415.06	690.11	679.36
Cash & Short-Term Investments	692.14	849.51	941.72	1,241	1,480
Cash Growth	-18.52%	-9.79%	-24.12%	-16.16%	-16.78%
Accounts Receivable	-	34.75	63.01	36.14	22.34
Other Receivables	-	227.7	2.37	10.55	1.13
Receivables	-	262.45	65.38	46.68	23.48
Inventory	-	41.06	59	55.61	38.62
Other Current Assets	-	69.6	36.68	62.78	35.2
Total Current Assets	-	1,223	1,103	1,406	1,578
Property, Plant & Equipment	-	393.31	793.02	728.06	605.76
Long-Term Investments	-	29.96	-	-	-
Other Intangible Assets	-	149.32	229.18	257.22	258.44
Long-Term Deferred Charges	-	2.03	0.94	2.74	3.12
Other Long-Term Assets	-	14.89	14.21	16.76	87.8
Total Assets	-	1,812	2,140	2,411	2,533
Accounts Payable	-	0.88	1.13	2.69	3.32
Accrued Expenses	-	25.11	37.39	41.84	38.98
Short-Term Debt	-	283.97	202.3	110.64	52.19
Current Portion of Long-Term Debt	-	43.01	104.06	46	227.77
Current Portion of Leases	-	0.23	2.4	4.42	5.09
Current Unearned Revenue	-	2.68	5.83	0.06	-
Other Current Liabilities	-	39.34	27.04	71.58	72.14
Total Current Liabilities	-	395.2	380.16	277.23	399.49
Long-Term Debt	-	79.36	71.42	117.12	7.5
Long-Term Leases	-	-	0.17	0.45	0.41
Long-Term Unearned Revenue	-	196.26	329.35	323.54	269.41
Other Long-Term Liabilities	-	-	16.35	21.08	25.59
Total Liabilities	-	670.83	797.44	739.41	702.41
Common Stock	-	374.58	374.58	374.58	359.76
Additional Paid-In Capital	-	2,723	2,723	2,723	2,540
Retained Earnings	-	-1,956	-1,755	-1,426	-1,069
Comprehensive Income & Other	-	0.02	0.01	0.03	-0.05
Total Common Equity	981.52	1,141	1,343	1,671	1,830
Shareholders' Equity	981.52	1,141	1,343	1,671	1,830
Total Liabilities & Equity	-	1,812	2,140	2,411	2,533
Total Debt	374.34	406.56	380.35	278.62	292.96
Net Cash (Debt)	317.8	442.95	561.37	962.38	1,187
Net Cash Growth	-28.25%	-21.09%	-41.67%	-18.94%	-32.01%
Net Cash Per Share	0.85	1.19	1.50	2.64	3.29
Filing Date Shares Outstanding	374.58	374.58	374.58	374.58	359.76
Total Common Shares Outstanding	374.58	374.58	374.58	374.58	359.76
Working Capital	-	827.41	722.63	1,129	1,178
Book Value Per Share	2.62	3.05	3.58	4.46	5.09
Tangible Book Value	848.58	991.99	1,114	1,414	1,572
Tangible Book Value Per Share	2.27	2.65	2.97	3.78	4.37
Buildings	-	159.06	76.22	76.22	-
Machinery	-	127.73	47.35	45.92	30.44
Construction In Progress	-	147.74	695.97	622.9	582.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.